Ureteral Stents Market - Global Outlook and Forecast 2021-2026

INDUSTRY INSIGHTS

The global ureteral stents market size will be valued at USD 371 million in 2026 and is expected to grow at a compound annual growth rate (CAGR) of 3% from 2020 to 2026. The industry is growing significantly due to the growing prevalence of several ureteral obstruction disorders primarily associated with kidney stones, kidney transplantation, and tumors worldwide.

The rising awareness of advanced treatment modalities for ureteral obstructions and the increasing availability of several effective urinary catheters and ureteral stents devices is a major factor contributing to the market growth. The ureteral stents market witnessed a decline in Q1 of 2020 on account of the coronavirus's eruption. Several affected countries postponed or delayed non-critical surgeries as most HCPs were deployed to tackle the pandemic. The ureteral stents procedures declined in Q1 & Q2 2020 as the number of surgical procedures estimated reduced in the short term, thereby delaying the new purchase of ureteral stent devices. Further, it is projected that the global market will witness YOY growth in the second half of the forecast period with the flattening of the COVID-19 curve and steady resumption of elective procedures.

SNIPPETS

• The increasing preference for ureteral stents surgery with advanced digital imaging techniques such as X-ray and fluoroscopy is a major factor in the global market.
• The growing focus on metallic stent presents other driving factors for the global ureteral stent market.
• The development of antimicrobial coated ureteral stents with improved safety and efficacy is likely to contribute to the market growth during the forecast period.
• The double pigtail segment is projected to witness an incremental growth of $55 million by 2025 due to the high efficiency of double pigtail stent to prevent the urinary tract's obstruction.
• The kidney stones segment is likely to experience an incremental growth of $31 million by 2025 due to the growing prevalence of kidney stones in the population, especially the elderly.

GLOBAL URETERAL STENTS MARKET SEGMENTATION

This research report includes a detailed segmentation by

1. Product
2. End-users
3. Application
4. Material
5. Geography

INSIGHTS BY PRODUCT

The double pigtail stents account for the largest share as most ureteric stents commercially available have a double pigtail structure. The market is likely to grow at a significant rate during the forecast period. Double pigtails, which are also referred to as double J/double pigtail (J) stents, are widely used in endourologic procedures to treat obstruction, pain, and infections for urologic procedures. Hence, the rise in endourologic procedures is expected to augur well for the segment.

The multiloop stents constituted close to 14% of the global ureteral stents market. These are also referred to as multilength ureteral stents and are intended to temporarily facilitate the drainage of urine from the kidney to the bladder. The majority of the multiloop ureteral stent is employed to relieve obstruction in a range of benign, malignant, and post-traumatic conditions as they permit the interim internal bypass drainage of urine when an obstruction in the ureter, particularly in the case of lithiasis, the availability of such clinical benefits is driving the growth.

INSIGHTS BY APPLICATION

The high prevalence of nephrolithiasis (kidney stones) in the elderly population is a major driver for the segment's growth. Nephrolithiasis has been associated with several comorbidities, including hypertension, diabetes mellitus, and metabolic syndrome (MeS). Therefore, a large patient pool and effective treatment of kidney stones are likely to aid in the segment's growth. Furthermore, key players focus on offering innovative ureteral stent materials for treating kidney stones, which effectively treat the disease.

The rise in chronic kidney disease (CKD) and its progression to ESRD remains a significant premature mortality source. CKD is a debilitating disease, and medical care standards for CKD involve aggressive monitoring for signs of disease progression and early referral to specialists for possible renal transplant. The ureteral stents placement for kidney transplantation helps reducing major urological complications. Therefore, the growth in CKD is a major factor influencing the growth of the segment.

INSIGHTS BY MATERIAL

In 2020, polymer ureteral stents accounted for over 87% of the global market. Polyurethane, silicone, C-flex, and Percuflex are the major polymers used to fabricate ureteral stents. The segment is likely to dominate the market as polyurethane material are easy to develop and have high drainage capacity. The polyurethane material has higher frictional forces during the placement and smaller side holes due to low tensile strength.

A metal ureteral stent is mainly designed to preserve long-term urinary drainage to avoid the need for frequent exchange. They are frequently used to treat complicated, malignant obstructions of the ureter and those urinary diseases, which are difficult to treat using conventional treatment methods or polymeric material. The application of metallic stents is growing as they are corrosion-resistant, MRI-compatible, and exhibit a strong tensile strength while offering satisfactory drainage under circumstances of extrinsic ureteral compression.

INSIGHTS BY END-USERS

The hospitals end-user segment accounted for a 50% share of the ureteral stents market. Healthcare professionals in hospitals are using a ureteral stent for treating kidney stones and other obstructions. The segment is growing at a healthy rate due to the high adoption of the latest generation devices. Most patients with a high risk of ureteral obstruction prefer visiting hospitals for diagnosis and treatment due to advanced infrastructure facilities in major private and public hospitals.

The urologic clinics end-user segment provides exclusive healthcare services to patients with suspected or diagnosed urological diseases. These centers are solely dedicated to treating patients suffering from several ureteral ailments such as CKD, ESRD, renal cancer, and kidney stones. The segment also offers sophisticated infrastructure related to the diagnosis and treatment of a broad spectrum of urological disorders, including ureteral obstructions. Therefore, these clinics can improve care by focusing considerably on clinical expertise and resources to treat patients suffering from kidney stones, complications related to kidney transplantation, tumors, and others.

INSIGHTS BY GEOGRAPHY

The North American ureteral stents market is mainly driven by high awareness of kidney-related ailments, a large pool of the patient population, technological advances and better products, and extensive reach of innovative products. The North American region is expected to witness lucrative growth during the forecast period due to the rising technological advancements that influence the higher uptake of easy to use medical devices, including ureteric stents. Besides, the increased healthcare spending by the population in countries, including the US and Canada, is further leading to the ureteral stents market growth in the region. Also, vendors' growing focus to develop advanced ureteral stent is likely to impact market growth significantly. Additionally, the region has several key vendors, such as Boston Scientific, Cook Medical, BD, offering a diverse range of products. Product innovations and modifications to existing devices by leveraging the latest technological platforms are likely to bring more effective and safer stents.

INSIGHTS BY VENDORS

The global ureteral stents market is highly competitive with the presence of global, regional, and local players offering a broad range of conventional and latest-generation devices. Boston Scientific, BD, Cook Medical, B. Braun Melsungen, and Coloplast are the key vendors in the market. These vendors have high expertise and reach in stent technology, material features, marketing strategies, and distribution channels. These companies have a wide geographic footprint, diversified product portfolio, and a strong focus on product innovation, R&D, and business expansion activities. Key players are likely to drive sales and margin growth in their business by expanding sales organization, securing additional contracts with commercial payors, maintaining technology leadership through R&D, and continuing to build clinical evidence to support the benefit of new products as well as services.

The ureteral stents market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

By Product

• Double Pigtail
• Multiloop
• Single Pigtail

By Application

• Kidney Stones
• Kidney Transplantation
• Tumors

By End-user

• Hospitals
• Urologic Clinics
• Outpatient Surgical Centers

By Geography

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
• APAC
  • China
  • Japan
  • South Korea
  • Australia
  • India
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Turkey